To see the efficacy of oral minoxidil versus topical minoxidil in male pattern hair loss.
Phase 3
- Conditions
- Health Condition 1: L649- Androgenic alopecia, unspecified
- Registration Number
- CTRI/2024/03/063576
- Lead Sponsor
- not applicable
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.All males aged 18-45 yrs of age
2. Males with ( Hamilton Norwood Scale II-IV)
Exclusion Criteria
1.Severe hypertension, moderate hypertension on
antihypertensive therapy
2.Cardiovascular dysfunction
3.History of minoxidil hypersensitivity
4.On treatment with formulation of minoxidil, DHT-
blockers or other treatments for AGA in the past 3 months.
5.Psychiatric or scalp disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Clinical photographic assessment and quantitative <br/ ><br>assessment using densitometer will be done. <br/ ><br>2.Hair density calculation will be done in a square inch <br/ ><br>areaTimepoint: every monthly for 6 months
- Secondary Outcome Measures
Name Time Method The number of vellus hairs, terminal hairs determined by their thickness in the specific square inch areaTimepoint: every monthly for 6 months